Aadi Bioscience Stock Performance
| AADI Stock | USD 2.22 0.08 3.48% |
On a scale of 0 to 100, Aadi Bioscience holds a performance score of 14. The firm shows a Beta (market volatility) of -0.0291, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Aadi Bioscience are expected to decrease at a much lower rate. During the bear market, Aadi Bioscience is likely to outperform the market. Please check Aadi Bioscience's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Aadi Bioscience's price patterns will revert.
Risk-Adjusted Performance
14 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 39.1 M |
Aadi |
Aadi Bioscience Relative Risk vs. Return Landscape
If you would invest 168.00 in Aadi Bioscience on August 28, 2024 and sell it today you would earn a total of 54.00 from holding Aadi Bioscience or generate 32.14% return on investment over 90 days. Aadi Bioscience is currently generating 0.4703% in daily expected returns and assumes 2.6266% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Aadi, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aadi Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aadi Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aadi Bioscience, and traders can use it to determine the average amount a Aadi Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.179
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AADI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.63 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.47 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Aadi Bioscience is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aadi Bioscience by adding it to a well-diversified portfolio.
Aadi Bioscience Fundamentals Growth
Aadi Stock prices reflect investors' perceptions of the future prospects and financial health of Aadi Bioscience, and Aadi Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aadi Stock performance.
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.49) % | ||||
| Current Valuation | (4.98 M) | ||||
| Shares Outstanding | 24.65 M | ||||
| Price To Book | 0.82 X | ||||
| Price To Sales | 2.26 X | ||||
| Revenue | 24.35 M | ||||
| EBITDA | (65.36 M) | ||||
| Cash And Equivalents | 118.74 M | ||||
| Cash Per Share | 5.65 X | ||||
| Total Debt | 1.27 M | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | 2.80 X | ||||
| Cash Flow From Operations | (59.66 M) | ||||
| Earnings Per Share | (2.28) X | ||||
| Total Asset | 132.42 M | ||||
| Retained Earnings | (268.96 M) | ||||
About Aadi Bioscience Performance
By evaluating Aadi Bioscience's fundamental ratios, stakeholders can gain valuable insights into Aadi Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aadi Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aadi Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.Things to note about Aadi Bioscience performance evaluation
Checking the ongoing alerts about Aadi Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aadi Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (18.78 M). | |
| Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Aadi Bioscience has a poor financial position based on the latest SEC disclosures |
- Analyzing Aadi Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aadi Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Aadi Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aadi Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aadi Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aadi Bioscience's stock. These opinions can provide insight into Aadi Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |